Blog Posts

Vraj Rangrej: Revolutionising Approaches to Lymphoma and CLL Therapies

Vraj Rangrej and Adam Kittai

Apr 1, 2025, 02:06

Vraj Rangrej: Revolutionising Approaches to Lymphoma and CLL Therapies

Vraj Rangrej, Visiting medical student at NewYork-Presbyterian Hospital, shared a post on LinkedIn:

“Revolutionising Approaches to Lymphoma and CLL Therapies

“Richter Transformation in the Era of Targeted therapies” from leading expert Dr. Adam Kittai, MD of Icahn School of Medicine at Mount Sinai.

– Optimizing BTK and BCL2 inhibitors for high-risk disease
– Emerging CAR-T approaches

A huge shoutout to the incredible team.

Special Thanks to Dr. Adam Kittai.”

Adam Kittai cancer CLL CLL Therapy lymphoma OncoDaily Oncology Vraj Rangrej

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Blog Posts

Aug 18, 2025, 15:59

Ashley Russo: 1 Month until Shave for the Brave

Insight

Aug 18, 2025, 15:59

Tatiana Prowell on the Regulatory Perspectives on CNS Disease in Clinical Trials

Blog Posts

Aug 18, 2025, 15:58

Gearing Up for WalkAway Cancer 2025 - Medicaid Cancer Foundation

Voices

Aug 18, 2025, 15:49

Palliative Care: Specialised Medical Care Approach Focused on Improving a Person's Quality of Life - UICC

Insight

Aug 18, 2025, 15:48

Antonio Giordano: First-in-Human Study of CDK2/4/6 Inhibitor PF-06873600 in Breast Cancer

Voices

Aug 18, 2025, 15:41

Arif Kamal: Rolling Together for More Rides - Helping People with Cancer to Get Treatment

Science

Aug 18, 2025, 15:34

Himanshu Mishra: Targeting DHODH to Reverse Immunosuppression and Overcome Anti-PD1 Resistance

Voices

Aug 18, 2025, 15:23

Important Advancement for Patients with Muscle Invasive Bladder Cancer - Natera

Science

Aug 18, 2025, 15:14

Rahul Banerjee Shared a Study Linking Bridging Intensity to Poor Outcomes After BCMA CAR-T

Science

Aug 18, 2025, 15:06

Applonia Rose: Whole-Body MRI As a Promising Radiation-Free Alternative to Conventional Imaging Methods

Insight

Aug 18, 2025, 15:02

Estela Rodriguez: AI to Predict Immunotherapy Response in Advanced NSCLC

Insight

Aug 18, 2025, 15:00

Amol Patel: Gallbladder Cancer is The Commonest Cancer in the Northern Parts of India